140 for 140

Global Recruitment

Great Minds for Grand Challenges

We are growing rapidly with research funding and students. Preparing for this and to mark our 140-year anniversary the Medical Faculty of the University of Hong Kong (HKUMed) is searching far and wide to find 140 new staff who are ready to dream big, find success, and make a difference.

The ‘140 for 140: Great Minds for Great Challenges’ campaign is recruiting candidates who are:

  • In clinical or non-clinical roles
  • In medicine, nursing, pharmacy, biomedical sciences, Chinese medicine, and public health
  • From anywhere in the world
  • Eager to be on the cutting edge doing impactful work

Our faculty’s support staff, tools, technology, funding, and systems keeps us at the forefront of research and understanding, and we hire the talent to match. We rank 28th globally among faculties for clinical, pre-clinical, and health, and 4th among all universities in Asia (T.H.E. 2020 Rankings).

Interested in joining HKUMed? Contact us through email at med140hr@hku.hk

Global Recruitment for an Additional 140 Professoriate Members by Our 140th Anniversary

Appointment Process and How to Apply

The University of Hong Kong will be supported in this appointment process by the executive search firm Perrett Laver. Perrett Laver will support the search committee in the discharge of its duties, both to assist in the assessment of candidates against the requirements for the role and identify the widest possible field of qualified candidates. 


Applications should consist of a full curriculum vitae detailing academic and professional qualifications, full employment history, and relevant achievements. CVs should be accompanied by a cover letter describing briefly how candidates meet the criteria outlined in the selection criteria, why the appointment is of interest, and what they believe they can bring to the role. 


Initial enquiries may be directed in confidence to Priscilla.Tse@perrettlaver.com or by phone +852 3619 8072.


As part of this process candidates may be invited to communicate with University representatives in person or by video conference. It is expected that final shortlisted candidates will be invited to interview at the University. Applicants should provide the names and contact details of at least three potential referees. These referees will not be approached without the proper consent of the applicant. 


The University of Hong Kong reserves the right to choose not to fill this role.


Protecting your personal data is of the utmost importance to Perrett Laver and we take this responsibility very seriously. Any information obtained by our trading divisions is held and processed in accordance with the relevant data protection legislation. The data you provide us with is securely stored on our computerised database and transferred to our clients for the purposes of presenting you as a candidate and/or considering your suitability for a role you have registered interest in.


As defined under the General Data Protection Regulation (GDPR) Perrett Laver is a Data Controller and a Data Processor, and our legal basis for processing your personal data is ‘Legitimate Interests’. You have the right to object to us processing your data in this way. For more information about this, your rights, and our approach to Data Protection and Privacy, please visit our website http://www.perrettlaver.com/information/privacy/  

More on the Faculty

The LKS Faculty of Medicine is the largest faculty within HKU, with over 400 full-time academic staff and 1,000 research and research-related support personnel. There are approximately 2,900 undergraduate and 1,600 postgraduate students. The Faculty receives substantial financial support for research activities from competitive grants, commissioned grants, contract research grants, conference grants, fellowships offered by the Government and various funding agencies, and donations made by professional and industrial bodies and individual benefactors.

Vision and Mission

The Faculty aspires to be a global leader in teaching and learning, research and discovery, clinical service and knowledge exchange in the professional domains of medicine, nursing, public health, pharmacy, Chinese medicine and in the biomedical and social sciences that underpin these professions. At the same time, we aim to nurture outstanding students who would go on to serve the people locally, nationally and around the world, thus leading to sustainable social development through better health.

Strategic Direction

The Faculty’s strategic direction places heavy emphasis on collaborative research efforts; Faculties and departments are not silos, they are an inextricable part of the University community, just as universities are a part of the wider community and international fields of knowledge. Regionally and internationally we also pride ourselves on our collaborative research agreements, public-private partnerships, world-class seminars and symposia, community workshops, and public outreach. 

As a reflection of such focus, funding and resources are readily available for all streams of research; we continue to lead by a very substantial margin in our predominant funding source, ie Health and Medical Research Fund which provides almost two-thirds of our individual competitive grant funding, with an accumulative sum that is 51% larger than the combined share for all the other local institutions. The recent establishment of the Centre for PanorOmic Sciences (CPOS) also strengthens the provision and development of cutting-edge core technological platforms, to support multi-omics research and training, and to undertake and oversee major strategic research programmes.

To enhance academic excellence and research outcomes, we have also gone above and beyond to foster greater internal, regional, and international collaboration. Five of the Faculty’s research centres, focusing on in cancer drug discovery, emerging infections, health data science, infectious disease immunology and stem cell biology, have been admitted into the Health@ and AIR@InnoHK clusters at the Hong Kong Science Park (HKSTP). In collaboration with the HKSTP will also prepare us for the establishment of Hong Kong’s first GMP facility, with the first cohort of staff scheduled to undergo traning soon at the Scottish National Blood Tranfusion Service.